- not yet recruiting
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study
This study is using smartwatches, phone apps, and AI to estimate a person's risk of Parkinson's disease early. It's for people aged 50 or over who are at risk of Parkinson's but don't have a diagnosis yet. The goal is to find ways to spot the disease sooner.
France · Spain · United Kingdom - not yet recruitingNA
Sensor-Based Optimization of Therapy for Parkinson's Disease Patients With Motor Fluctuations
This study looks at whether smart wearable sensors, worn at home, can help doctors better adjust medicine for people with Parkinson's disease. The goal is to improve movement and daily life by giving doctors more information than traditional check-ups.
France - active not recruitingNA
Enhanced Tai Chi for Parkinson's Disease (Enhanced Tai Chi PD)
This study is testing if a special Tai Chi program helps people with Parkinson's disease. It looks at how it affects movement problems like balance, and other issues like tiredness or sleep. Researchers want to see if this Tai Chi is helpful and can improve daily life.
United Kingdom - recruiting
Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
This study is testing smart socks called DANU to see how well they measure walking and balance in people with Parkinson's. Researchers want to check if these socks can help predict falls and if the measurements are accurate compared to standard equipment.
United Kingdom - recruiting
Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease
This study looks at how new 'smart socks' called DANU can help understand walking and balance in people with Parkinson's. Researchers will compare people with Parkinson's and healthy individuals to see if the sock data links to Parkinson's symptoms and disease changes.
United Kingdom - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A study to find out how healthy people tolerate a new drug called S221237.
This study is testing a new drug, S221237, in healthy people to see how they react to it for the first time. We want to understand if it's safe and how the body handles it. This is a very early step in checking if the drug could one day help people with Parkinson's disease.
France